Development Environmentv0.16.0Development Environmentv0.16.0Development Environmentv0.16.0Development Environmentv0.16.0Development Environmentv0.16.0Development Environmentv0.16.0Development Environmentv0.16.0Development Environmentv0.16.0
Development Environmentv0.16.0Development Environmentv0.16.0Development Environmentv0.16.0Development Environmentv0.16.0Development Environmentv0.16.0Development Environmentv0.16.0Development Environmentv0.16.0Development Environmentv0.16.0

Myasthenia Gravis (suspected diagnosis or established diagnosis)

Myasthenia gravis is a chronic autoimmune neuromuscular disorder with a bimodal age distribution classified as early onset (age 20s-30s, women > men and late-onset (age 60s-80s men > female). Symptoms may seem relatively non-specific. A history of fatiguing/fluctuating weakness involving preferentially affected muscle groups adds to diagnostic certainty.

Last updated 3/22/2026

Symptoms

Triggers for Exacerbation

Current Work-up

Disease History (for patients with established diagnosis of myasthenia gravis)

HIPAA: Only the year will appear in summaries

Myasthenia Gravis (suspected diagnosis or established diagnosis) | NeuroNav